BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Nov. 3, 2006
View Archived Issues
XOMA, Takeda In Antibody Deal With $100M Potential
XOMA Ltd. could receive more than $100 million in a collaboration with Takeda Pharmaceutical Co. Ltd. to discover and develop monoclonal antibody therapeutics. (BioWorld Today)
Read More
Exelixis' Stock Falls After XL999 Phase II Suspension
Read More
TopoTarget, LEO Deal Gives CuraGen Payoff For License
Read More
Gamida Cell Earns SPA To Begin Phase III For StemEx
Read More
Clinic Roundup
Read More
Other News To Note
Read More
Appointments And Advancements
Read More